A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

The White House budget office rescinded the funding freeze, but Trump will still attempt to pull back funding from “woke” ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

"The government cannot be a welfare program for everybody doing low quality, low credibility, irreproducible, low value of ...

At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has ...

HHS announced plans to reevaluate agency practices to ensure they meet requirements under the Hyde Amendment, which prohibits ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...